MARKET

MITO

MITO

Stealth BioTherapeutics
NASDAQ

Real-time Quotes | Nasdaq Last Sale

1.380
+0.020
+1.47%
Closed 19:59 07/29 EDT
OPEN
1.360
PREV CLOSE
1.360
HIGH
1.410
LOW
1.360
VOLUME
108.32K
TURNOVER
--
52 WEEK HIGH
2.580
52 WEEK LOW
1.060
MARKET CAP
78.72M
P/E (TTM)
-1.4042
1D
5D
1M
3M
1Y
5Y
Stealth BioTherapeutics (MITO) Sees Hammer Chart Pattern: Time to Buy?
Stealth BioTherapeutics (MITO) has been struggling lately, but the selling pressure may be coming to an end soon.
Zacks · 07/08 10:11
Stealth Biotherapeutics joins Rare Disease Company Coalition
Stealth BioTherapeutics (MITO) has joined the Rare Disease Company Coalition, an alliance of life science companies committed to discovering, developing, and delivering rare disease treatments.The coalition will engage with policy stakeholders
Seekingalpha · 07/07 20:34
Stealth BioTherapeutics Says Joins Rare Disease Company Coalition
Stealth BioTherapeutics Corp (NASDAQ:MITO), a clinical-stage biotechnology company focused on the discovery, development, and commercialization of novel therapies for diseases involving mitochondrial dysfunction, today
Benzinga · 07/07 20:30
Stealth BioTherapeutics'(NASDAQ:MITO) Share Price Is Down 19% Over The Past Year.
The simplest way to benefit from a rising market is to buy an index fund. While individual stocks can be big winners...
Simply Wall St. · 07/06 10:23
Benzinga's Top Ratings Upgrades, Downgrades For July 1, 2021
Upgrades
Benzinga · 07/01 14:11
Maxim Group Initiates Coverage On Stealth BioTherapeutics with Buy Rating, Announces Price Target of $3
Maxim Group analyst Jason McCarthy initiates coverage on Stealth BioTherapeutics (NASDAQ:MITO) with a Buy rating and announces Price Target of $3.
Benzinga · 07/01 12:35
Microcaps mostly among premarkets gainers
Alterity Therapeutics Limited (ATHE) +57% on a new patent by USPTO.Birks Group (BGI) +49% on re-opening of its retail stores across Canada.Wunong Net Technology Company (WNW) +46%.Spero Therapeutics (SPRO) +23% on $40M equity
Seekingalpha · 07/01 12:24
Is MITO Stock A Buy Here?
In this article we will analyze whether Stealth BioTherapeutics Corp (NASDAQ:MITO) is a good investment right now by following the lead of some of the best investors in the world and piggybacking their ideas. There’s no better way to get these firms’ immen...
Insider Monkey · 06/18 15:38
More
Forecast
Actual (USD)
Estimate (USD)
Income StatementMore
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
Operating (USD)
YoY (%)
Learn about the latest financial forecast of MITO. Analyze the recent business situations of Stealth BioTherapeutics through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 4 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average MITO stock price target is 3.250 with a high estimate of 4.000 and a low estimate of 2.000.
EPS
Institutional Holdings
Institutions: 23
Institutional Holdings: 2.74M
% Owned: 4.80%
Shares Outstanding: 57.04M
TypeInstitutionsShares
Increased
6
1.15M
New
5
501.95K
Decreased
0
0
Sold Out
5
151.46K
  • Performance
  • Asset Allocation
  • Dividend History
No Data
No Data
No Data
About MITO
Stealth BioTherapeutics Corp. is a clinical-stage biotechnology company focused on the discovery, development and commercialization of novel therapies for diseases involving mitochondrial dysfunction. The Company is primarily focused on developing mitochondrial targeted therapies for diseases with clear unmet medical needs including cardiovascular, renal, neurodegenerative and metabolic diseases. The Company is engaged in developing its product pipelines, which include Elamipretide, SBT-20 and SBT-272.

Webull offers kinds of Stealth BioTherapeutics Corp stock information, including NASDAQ:MITO real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, MITO stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading MITO stock methods without spending real money on the virtual paper trading platform.